Amira Khater/LinkedIn
Feb 23, 2026, 15:16
Amira Khater: Key Updates on Pulmonary Embolism Management from AHA and ACC Guidelines
Amira Khater, Clinical Pharmacy Specialist at Sentara Healthcare, shared on LinkedIn:
“The AHA and ACC just released their first-ever joint guideline on acute pulmonary embolism, bringing clearer structure to how we diagnose and manage PE.
A few key updates that stood out to me:
- A new A–E classification system to better define PE severity and guide treatment
- DOACs remain first-line for most patients needing anticoagulation
- Advanced therapies like thrombolysis are reserved for higher-risk patients with clinical deterioration
- Greater emphasis on risk stratification and follow-up care
This is an important step toward more consistent, risk-based care—and highlights the ongoing role of the multidisciplinary team in improving outcomes for patients with PE.”
Stay updated on all scientific advances with Hemostasis Today.
-
May 26, 2026, 16:45Ashley George: Take the Leap for Thrombosis UK
-
May 26, 2026, 16:40Hamed Helisaz: Machine Learning for Detecting Missing Heart Medications
-
May 26, 2026, 15:32Haroun Gajraj: Brown Marks After Microsclerotherapy – What Every Practitioner Needs to Know
-
May 26, 2026, 15:29Jacqueline van Paassen: Lack of Essential Clinical Data in DOAC Prescriptions in Community Pharmacies
-
May 26, 2026, 15:22Shazmah Shaikh: One Visual Guide to Understand All Major Anticoagulants
-
May 26, 2026, 14:39Chidinma Favour։ Welcome to Day 25 of My 31-Day Stroke Awareness Series
-
May 26, 2026, 14:35Novel Insights Into Congenital and Acquired Coagulopathies – ICHCC
-
May 26, 2026, 14:24Fernanda Orsi: The Growing Impact of Hematology Research in Latin America
-
May 26, 2026, 14:23Rense Buijvoets: What If Clots Could Be Treated Exactly Where They Form?